According to the latest data from the Hong Kong Stock Exchange, Morgan Stanley increased its position in NOVOSENSE (02676) on June 25th.
The financial institution purchased 105,836 shares at an average price of approximately HK$221.92 per share.
The total consideration for this transaction amounted to roughly HK$23.4871 million.
Following this acquisition, Morgan Stanley's latest shareholding stands at about 1.6538 million shares, representing an 8.22% stake in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.